IDEXX Laboratories Introduces LabREXX® Electronic Test Request Forms [Trade]
A new way to create bar-coded test order forms for IDEXX Cornerstone® Practice Management System

Westbrook, Maine, January 12, 2007—IDEXX Computer Systems, a division of IDEXX Laboratories, Inc. (NASDAQ:IDXX), introduces LabREXX®—software that provides veterinary practices with a fast and accurate way to request tests from IDEXX Reference Laboratories. LabREXX functionality uses SmartLink™ Technology to integrate critical patient and practice information to create a “complete circuit” of data flow that simplifies tasks, saves steps and streamlines the entire point-of-care process.

A new feature of the IDEXX Cornerstone® Practice Management System, LabREXX automatically populates the test order forms with client and patient information drawn directly from the Cornerstone patient record, eliminating the need for handwritten test requisition forms. LabREXX forms also help avoid mistakes by ensuring that the test ordered is appropriate for the patient’s species. All of this information is encoded in a two-dimensional bar code, which is scanned at the lab for foolproof capture of the order.

LabREXX also works with the Cornerstone Reference Lab module to make test results more accessible. Once the test result is received from the reference laboratory, the IDEXX Cornerstone Reference Lab module automatically downloads results directly into the patient medical record. Best of all, LabREXX virtually eliminates missed charges by auto-transferring ordered tests to client invoices.

“By implementing LabREXX, our staff no longer fills out manual request forms or re-keys patient data. With Cornerstone’s automated invoicing feature, missed and lost charges are a thing of the past. The impact to my practice is higher efficiency, quicker access to patient data, and a 17% or $2,125 per month increase in lab revenue to the practice,” said Trevor Lyon, RVT, Hospital Manager for Bells Ferry Veterinary Hospital, Acworth, Georgia.

For more information on LabREXX and Cornerstone software, visit www.idexx.com/labrexx, e-mail computer-sales@idexx.com or call 1-800-283-8386.

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice-management systems, and therapeutics. Our products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Westbrook, Maine, IDEXX Laboratories employs more than 3,500 people and offers products to customers in over 100 countries.

Note Regarding Forward-Looking Statements
This press release contains statements about the Company’s business prospects that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management’s expectations. Factors that could cause or contribute to such differences include the following: the Company’s ability to develop, manufacture, introduce and market new products and enhancements to existing products; the effectiveness of the Company’s sales and marketing activities; the Company’s ability to develop, license or obtain rights to new technologies; the Company’s ability to identify acquisition opportunities, complete acquisitions and integrate acquired businesses; the impact of competition and technological change on the markets for the Company’s products; the effect of government regulation on the Company’s business, including government decisions about whether and when to approve the Company’s products and decisions regarding labeling, manufacturing and marketing products; the impact of distributor purchasing decisions on sales of our products that are sold through distribution; changes or trends in veterinary medicine that affect the rate of use of the Company’s products and services by veterinarians; the Company’s ability to obtain patent and other intellectual property protection for its products, successfully enforce its intellectual property rights and defend itself against third party claims against the Company; disruptions, shortages or pricing changes that affect the Company’s purchases of products and materials from third parties, including from sole source suppliers; the effects of government regulatory decisions, customer demand, pricing and other factors on the realizability of the Company’s inventories; the Company’s ability to manufacture complex biologic products; the effects of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the loss of key employees. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2005 (1.5 MB), and on the Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 (520 KB), in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations."

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe^® Reader^® software.